Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8545 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8434 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8402 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8353 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8263 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8199 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8114 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8072 |
Intermediate Similarity |
NPD920 |
Approved |
0.8034 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD919 |
Approved |
0.8012 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7886 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7844 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7844 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7824 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7759 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7725 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7719 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7717 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7593 |
Intermediate Similarity |
NPD943 |
Approved |
0.7593 |
Intermediate Similarity |
NPD1240 |
Approved |
0.759 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7576 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.756 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7541 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.75 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7439 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.738 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7294 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD37 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7204 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7118 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7118 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7066 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7056 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7043 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7907 |
Approved |
0.703 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7024 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7011 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7 |
Intermediate Similarity |
NPD8313 |
Approved |
0.6988 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6946 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6944 |
Remote Similarity |
NPD6279 |
Approved |
0.6944 |
Remote Similarity |
NPD6280 |
Approved |
0.6935 |
Remote Similarity |
NPD6776 |
Approved |
0.6935 |
Remote Similarity |
NPD6782 |
Approved |
0.6935 |
Remote Similarity |
NPD6780 |
Approved |
0.6935 |
Remote Similarity |
NPD6781 |
Approved |
0.6935 |
Remote Similarity |
NPD6777 |
Approved |
0.6935 |
Remote Similarity |
NPD6779 |
Approved |
0.6935 |
Remote Similarity |
NPD6778 |
Approved |
0.6932 |
Remote Similarity |
NPD5401 |
Approved |
0.6912 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6907 |
Remote Similarity |
NPD4287 |
Approved |
0.6904 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6904 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6875 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6857 |
Remote Similarity |
NPD6190 |
Approved |
0.6853 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6829 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6826 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6816 |
Remote Similarity |
NPD1653 |
Approved |
0.6806 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.68 |
Remote Similarity |
NPD8166 |
Discontinued |
0.68 |
Remote Similarity |
NPD7003 |
Approved |
0.6798 |
Remote Similarity |
NPD6273 |
Approved |
0.6791 |
Remote Similarity |
NPD5242 |
Approved |
0.6788 |
Remote Similarity |
NPD6696 |
Suspended |
0.6786 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6782 |
Remote Similarity |
NPD3057 |
Approved |
0.6782 |
Remote Similarity |
NPD2491 |
Approved |
0.6774 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6768 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD3972 |
Approved |
0.6766 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6765 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6763 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6762 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6749 |
Remote Similarity |
NPD7697 |
Approved |
0.6749 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6749 |
Remote Similarity |
NPD7698 |
Approved |
0.6747 |
Remote Similarity |
NPD1203 |
Approved |
0.6746 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD2654 |
Approved |
0.6729 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6725 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD6764 |
Approved |
0.6719 |
Remote Similarity |
NPD6765 |
Approved |
0.6719 |
Remote Similarity |
NPD7240 |
Approved |
0.6716 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6716 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD2798 |
Approved |
0.6707 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6703 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.67 |
Remote Similarity |
NPD3533 |
Approved |
0.67 |
Remote Similarity |
NPD3448 |
Approved |
0.67
|
Remote Similarity |
NPD2972 |
Approved |